Medicare Enrolled

Dr. Richard Cherlin, M.D.

Endocrinology · Los Gatos, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
15899 LOS GATOS ALMADEN RD, Los Gatos, CA 95032
4083582663
In practice since 2006 (20 years)
NPI: 1922060219 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cherlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cherlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cherlin

Dr. Richard Cherlin is an endocrinology specialist in Los Gatos, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cherlin performed 1,728 Medicare services across 918 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cherlin received a total of $16,354 from 63 pharmaceutical and/or device companies across 829 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cherlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 31% volume in CA $16,354 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,728
Medicare services
Top 31% in CA for endocrinology
918
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,287 $77 $325
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
170 $13 $65
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
98 $110 $460
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
81 $46 $200
New patient office visit, complex (60-74 min) 47 $178 $770
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
45 $8 $9
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,354
Total received (2018-2024)
Avg $2,336/year across 7 years
Top 13% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
829
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,118 (86.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,236 (13.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,280
2023
$3,886
2022
$1,983
2021
$2,364
2020
$2,058
2019
$1,731
2018
$2,051

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$488
Lilly USA, LLC
$302
Amgen Inc.
$175
Antares Pharma, Inc.
$173
ABBVIE INC.
$170
Bayer Healthcare Pharmaceuticals Inc.
$161
BETA BIONICS, INC.
$159
Dexcom, Inc.
$91
Mannkind Corporation
$85
Radius Health, Inc.
$74
Verity Pharmaceuticals Inc.
$61
Ascensia Diabetes Care Us Inc.
$57
SANOFI-AVENTIS U.S. LLC
$49
Xeris Pharmaceuticals, Inc.
$46
Abbott Laboratories
$42
IBSA Pharma Inc.
$41
Novartis Pharmaceuticals Corporation
$27
Alexion Pharmaceuticals, Inc.
$24
VIVUS LLC
$22
Currax Pharmaceuticals LLC
$18
Almatica Pharma LLC
$15
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,028
Lilly USA, LLC
$1,919
Acella Pharmaceuticals, LLC
$1,185
Amgen Inc.
$917
SANOFI-AVENTIS U.S. LLC
$914
Abbott Laboratories
$886
Antares Pharma, Inc.
$666
Radius Health, Inc.
$601
Mannkind Corporation
$505
AstraZeneca Pharmaceuticals LP
$410
Bayer Healthcare Pharmaceuticals Inc.
$390
IBSA Pharma Inc.
$372
Xeris Pharmaceuticals, Inc.
$369
Shire North American Group Inc
$348
Merck Sharp & Dohme Corporation
$324
Janssen Pharmaceuticals, Inc
$306
Eko Health, Inc.
$300
MannKind Corporation
$292
ABBVIE INC.
$217
AbbVie, Inc.
$217
Amarin Pharma Inc.
$214
Eko Devices, Inc.
$200
Corcept Therapeutics
$199
Dexcom, Inc.
$194
AbbVie Inc.
$189
Horizon Therapeutics plc
$181
Medtronic, Inc.
$179
BETA BIONICS, INC.
$159
Supernus Pharmaceuticals, Inc.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$154
Insulet Corporation
$120
Ascensia Diabetes Care Us Inc.
$114
Chiasma, Inc.
$99
Zealand Pharma US, Inc.
$75
Novartis Pharmaceuticals Corporation
$70
Kowa Pharmaceuticals America, Inc.
$69
CeQur Corporation
$62
Ultragenyx Pharmaceutical Inc.
$62
Verity Pharmaceuticals Inc.
$61
Bayer HealthCare Pharmaceuticals Inc.
$54
Amryt Pharma Holdings Ltd
$49
PFIZER INC.
$43
Tandem Diabetes Care, Inc.
$39
Alexion Pharmaceuticals, Inc.
$37
RECORDATI_RARE_DISEASES_INC.
$37
Merck Sharp & Dohme LLC
$35
VIVUS, Inc.
$32
Ascendis Pharma Inc
$27
Embecta Corp.
$23
Clarus Therapeutics Inc.
$23
VIVUS LLC
$22
Ipsen Biopharmaceuticals, Inc
$21
Medtronic MiniMed, Inc.
$20
Avanir Pharmaceuticals, Inc.
$19
iRhythm Technologies, Inc.
$19
Lupin Inc.
$18
Currax Pharmaceuticals LLC
$18
Aytu BioScience, Inc
$18
EUSA Pharma (US) LLC
$16
Nalpropion Pharmaceuticals LLC
$16
Almatica Pharma LLC
$15
Allergan Inc.
$14
Kyowa Kirin, Inc.
$14
Top 3 companies account for 31.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ANTARA · BAQSIMI · BD Nano 2nd Gen Pen Needle · BYDUREON · BYSTOLIC · CONTRAVE · CeQur Simplicity · Crysvita · DEXCOM CGM · DIABETES - DISEASE · Dexcom G6 Transmitter · EFPEGLENATIDE · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LEQVIO · LICART · Livalo · MINIMED 770G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NP Thyroid 60 · NUEDEXTA · Natesto · OTREXUP · Omnipod · Otrexup · Ozempic · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · SOTAGLIFLOZIN · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tymlos · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · ZEPBOUND · ZIO XT Patch · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Los Gatos?
Compare endocrinologists in the Los Gatos area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
84
Per 100K population
4.4
County median income
$159,674
Nearest hospital
HAZEL HAWKINS MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Cherlin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Cherlin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Cherlin performed 1,287 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cherlin receive payments from pharmaceutical companies?
Yes. Dr. Cherlin received a total of $16,354 from 63 companies across 829 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cherlin's costs compare to other endocrinologists in Los Gatos?
Dr. Cherlin's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cherlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →